The Influence of Tumor Microenvironment on Immune Escape of Melanoma

The Influence of Tumor Microenvironment on Immune Escape of Melanoma

The low efficiency of currently-used anti-cancer therapies poses a serious challenge, especially in the case of malignant melanoma, a cancer characterized by elevated invasiveness and relatively high mortality rate. The role of the tumor microenvironment in the progression of melanoma and its acquis...

Full description

Bibliographic Details
Main Authors:	Aleksandra Simiczyjew, Ewelina Dratkiewicz, Justyna Mazurkiewicz, Marcin Ziętek, Rafał Matkowski, Dorota Nowak
Format:	Article
Language:	English
Published:	MDPI AG 2020-11-01
Series:	International Journal of Molecular Sciences
Subjects:	immune cells melanoma targeted therapies drugs resistance
Online Access:	https://www.mdpi.com/1422-0067/21/21/8359

Similar Items

Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy
by: Justyna Mazurkiewicz, et al.
Published: (2021-01-01)

Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance
by: Ewelina Dratkiewicz, et al.
Published: (2021-04-01)

Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells’ Invasive Abilities
by: Aleksandra Simiczyjew, et al.
Published: (2019-10-01)

Melanoma stimulates the proteolytic activity of HaCaT keratinocytes
by: Justyna Mazurkiewicz, et al.
Published: (2022-09-01)

Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche
by: Aleksandra Simiczyjew, et al.
Published: (2023-07-01)

Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts
by: Justyna Mazurkiewicz, et al.
Published: (2022-05-01)

PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma—A Clinical and an In Vitro Study
by: Piotr Kupczyk, et al.
Published: (2021-01-01)

Melanoma: tumor microenvironment and new treatments
by: Mara Huffenbaecher Giavina-Bianchi, et al.
Published: (2017-03-01)

The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma
by: Wencheng Zhou, et al.
Published: (2022-12-01)

Severe complications of nivolumab monotherapy in an adolescent with malignant melanoma
by: Aleksandra Grzegorczyk, et al.
Published: (2023-08-01)

Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy
by: Italia Falcone, et al.
Published: (2020-10-01)

Introduction of a pilot program to measure and improve the clinical care of melanoma patients in the Lower Silesian Voivodeship in Poland: a report of 20 months experience
by: Marcin Ziętek, et al.
Published: (2022-11-01)

Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment
by: Naji Kharouf, et al.
Published: (2023-06-01)

An analysis of clinical effectiveness of electrochemotherapy in the treatment of advanced metastatic malignant melanoma performed in the eastern part of Central Europe: a single-centre experience
by: Marcin Ziętek, et al.
Published: (2022-07-01)

Alpha-Enolase (ENO1) Correlates with Invasiveness of Cutaneous Melanoma—An In Vitro and a Clinical Study
by: Miriam Hippner, et al.
Published: (2022-01-01)

Characterization and Quantitation of the Tumor Microenvironment of Uveal Melanoma
by: Lara Goesmann, et al.
Published: (2023-05-01)

Involvement of β- and γ-actin isoforms in actin cytoskeleton organization and migration abilities of bleb-forming human colon cancer cells.
by: Aleksandra Simiczyjew, et al.
Published: (2017-01-01)

Outcomes of Patients with Metastatic Melanoma—A Single-Institution Retrospective Analysis
by: Lidia Szatkowska, et al.
Published: (2022-03-01)

The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
by: Rita Cabrita, et al.
Published: (2020-03-01)

Melanogenesis and the Targeted Therapy of Melanoma
by: Cang Li, et al.
Published: (2022-12-01)

Immune Score Indicator for the Survival of Melanoma Patients Based on Tumor Microenvironment
by: Ning X, et al.
Published: (2021-12-01)

The Interplay between Tumour Microenvironment Components in Malignant Melanoma
by: Cornelia Amalinei, et al.
Published: (2022-03-01)

Melanoma: Attacking on Many Fronts
by: Michael A. Thompson
Published: (2014-01-01)

Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment
by: Anna Maria Lucianò, et al.
Published: (2023-07-01)

MITF induces escape from innate immunity in melanoma
by: Luis Sánchez-del-Campo, et al.
Published: (2021-03-01)

Exploring Tumor Immune Microenvironment and Its Associations With Molecular Characteristics in Melanoma
by: Jiangyuan Wang, et al.
Published: (2022-04-01)

Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
by: Shamik Mitra, et al.
Published: (2020-05-01)

Clinical Significance of Tumor Microenvironment in Acral Melanoma: A Large Single-Institution Study of Caucasians
by: Aneta Maria Borkowska, et al.
Published: (2021-04-01)

Incidence of different types of cancer in the follow-up period after primary diagnosis and treatment of melanoma. Single-center 4-years follow-up on a population of 709 patients
by: Marcin Ziętek, et al.
Published: (2023-06-01)

Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape
by: Veronica Romano, et al.
Published: (2021-05-01)

Melanoma treatment in review
by: Domingues B, et al.
Published: (2018-06-01)

Clinical practice consensus for the diagnosis and management of melanoma in Taiwan
by: Chiao-En Wu, et al.
Published: (2024-01-01)

Nucleoli cytomorphology in cutaneous melanoma cells – a new prognostic approach to an old concept
by: Piotr Donizy, et al.
Published: (2017-12-01)

Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma
by: Helene Schäfer, et al.
Published: (2023-09-01)

The Role of Hedgehog Signaling in the Melanoma Tumor Bone Microenvironment
by: Karnoon Shamsoon, et al.
Published: (2023-05-01)

Understanding the Microenvironment of Melanoma Cells for the Development of Target Drug Delivery Systems
by: Lucas B. Naves, et al.
Published: (2017-10-01)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
by: Dan Liu, et al.
Published: (2021-05-01)

The expression pattern of immune-related genes and characterization of tumor immune microenvironment: predicting prognosis and immunotherapeutic effects in cutaneous melanoma
by: Dong Dong, et al.
Published: (2022-09-01)

Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma
by: Francesca Comito, et al.
Published: (2022-01-01)

Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy
by: Miguel-Angel Berciano-Guerrero, et al.
Published: (2022-01-01)